Rethink Pharmaceuticals Information

We discover new indications for drugs in the market and under clinical development, as well as shelved drugs which failed for efficacy reasons in clinical trials. Our breakthrough approach goes beyond the boundaries of published data (whereas other companies are based on the same data-sets) dramatically expanding the spectrum of connections between drugs and diseases that allows us to generate novel and highly accurate findings. We look to work in partnership and collaboration with the pharma industry, medical institutions and rare disease foundations to create value by enhancing the potential clinical and commercial success of repurposing options for existing assets. Meet the team